Forbes Breaking News
@ForbesBreakingNews·5.5M subscribers·180.5K videos
Elena Kagan Asks Lawyer 'How Much Patent Review The FDA Is Doing' When Approving Generic Drugs
Posted
May 4, 2026
Views
132
Likes
3
Engagement
2.27%
May 4, 2026
132
3
2.27%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:03Now PlayingWhile hearing oral arguments for Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. last week, Associate Justice Elena Kagan asked Deputy Solicitor General Malcolm L. Stewart, arguing as amicus curiae, about patent approvals for generic drugs.
Stay Connected
Forbes Breaking News on X
Forbes Breaking News on TikTok
More From Forbes
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
